Associate Professor Dr David Pattison
Deputy Director / Senior Staff Specialist, Department of Nuclear Medicine & Specialised Pet Services Rbwh
David underwent dual specialty training in both Endocrinology and Nuclear Medicine at Royal Melbourne Hospital, Austin Hospital and Peter MacCallum Cancer Centre in Melbourne.
He was appointed a staff specialist at Peter MacCallum Cancer Centre at the completion of his training and moved to Royal Brisbane & Women’s Hospital in 2016 where he is currently the Deputy Director of Department of Nuclear Medicine & Specialised PET Services, nuclear medicine lead for the RBWH radionuclide therapy service and supervises postgraduate students at University of Queensland.
His research interests are at the intersection of nuclear medicine & endocrinology - neuroendocrine tumours & thyroid cancer - and prostate cancer theranostics.
He has been a chief investigator on several large competitive grants for theranostics, including redifferentiation of radioactive iodine refractory thyroid cancer (I-FIRST $2.7 million MRFF 2021), prostate cancer (UpFrontPSMA $4 million Movember/Cancer Australia 2019) and merkel cell cancer (GoTHAM $1.8 million MRFF 2018).
He also recently led a Queensland Health New Technology Funding and Evaluation Program grant for implementation of a clinical I-124 PET/CT service for staging and prospective dosimetry of metastatic thyroid cancer.
Pre-Conference Symposium is proudly sponsored by: